unknown
Stage
About
Gen1E is a drug development company that uses an AI platform to screen for treatments for rare inflammatory diseases such as ARDS, ALS, and cystic fibrosis; it reports a pipeline of 21 compounds and has completed Phase I for a lead ARDS compound.
Explore Gen1E's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.